Effect of Docosahexaenoic Acid on Apoptosis and Proliferation in the Placenta: Preliminary Report

Table 1

Clinical data and the activity of caspase 3 and the concentration of DHA in the serum of venous cord blood in patients from both analyzed groups.

Variable	Median	Min–max	95% CI	value
Maternal age (y)
DHA group ()	25,5	19–39	25,2–26,7	0,5399
Control group ()	26	18–35	24,2–26,8
Gestational age (w)
DHA group ()	39,5	37,8–41,2	39,26–39,64	0,2151
Control group ()	39,20	37,6–41
Birth weight (g)
DHA group ()	3675	2990–4350	3589–3760	0,8815
Control group ()	3785	3170–4400	3725–3844
Placenta weight (g)
DHA group ()	510	440–650	497–522	0,0071
Control group ()	530	410–610	522–537
Apgar score at 5 minutes (p)
DHA group ()	10	8–10	9,87–10,13	1,0000
Control group ()	10	7–10	9,88–10,12
Caspase 3 activity (mol pNa/min/mL)
DHA group ()	0,053	0,0084–0,048	0,0511–0,0549	0,0001
Control group ()	0,059	0,0047–0,049	0,0582–0,0598
Cord DHA (ng/L)
DHA group ()	3,86	3,54–4,13	3,83–3,89	0,0001
Control group ()	3,61	3,49–3,79	3,60–3,62